Skip to main content

Nonprofit · EIN 75-1835298

SUSAN G KOMEN BREAST CANCER FOUNDATION

Also known as SUSAN G KOMEN FOR THE CURE

Tax-exempt · DALLAS, TX 75380

Financials

$102.9M$111.5M2023$103.2M$110.5M2024
Revenue Expenses · by fiscal year end
Financials of SUSAN G KOMEN BREAST CANCER FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
March 31, 2025990$103,154,379$110,497,282-$7,342,903$178,872,555$54,765,664$124,106,891
March 31, 2024990$102,934,186$111,489,604-$8,555,418$188,139,545$58,636,745$129,502,800
Financial details: 990 for the year ended March 31, 2025

Revenue

Contributions, gifts and grants
$102,783,181
Program service revenue
$0
Investment income
$6,255,060
Royalties
$51,000
Net gain from sales of assets
$3,880,936
Net income from fundraising events
-$6,174,727
Net income from gaming
$8,231
Net income from sales of inventory
$73,000
Other revenue
-$5,883,862

Expenses

Grants and similar amounts paid
$18,581,010
Compensation of officers, directors and key employees
$2,538,009
Other salaries and wages
$40,350,074
Salaries, compensation and benefits (total)
$51,571,757
Professional fundraising fees
$2,054,814
Legal fees
$188,069
Accounting fees
$361,235
Occupancy
$155,237
Travel
$983,085
Depreciation
$1,289,614
Program services (functional)
$71,229,097
Management and general (functional)
$12,674,324
Fundraising (functional)
$26,593,861

Balance sheet and other

Total assets, start of year
$188,139,545
Total assets, end of year
$178,872,555
Total liabilities, end of year
$54,765,664
Net assets, end of year
$124,106,891
Land, buildings and equipment
$2,830,138
Publicly traded securities
$106,384,407
Net assets without donor restrictions
$84,977,043
Net assets with donor restrictions
$39,129,848
Gross unrelated business income
$8,698
Gross receipts
$138,937,712
Employees
482
Volunteers
9,977
Year formed
1982
State of legal domicile
TX

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended March 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Paula SchneiderPresident and CEO
Officer
55$658,115$30,697
Ria WilliamsChief Financial Officer
Officer
55$323,478$36,314
Eunice NakamuraGeneral Counsel and Corporate Secretary (Ending Feb-2025)
Officer
55$311,206$24,533
Catherine OlivieriSVP, Human Resources
Key employee
55$270,792$27,128
Kathryn WattSVP, Community Development & Operations
Key employee
55$265,455$29,529
Sarah RosalesVP, Corporate Partnerships
Key employee
55$259,602$32,314
Victoria SmartSVP, Mission
Key employee
55$265,909$2,935
Nicholas Michael DiFranzaVP, Information Technology
Highest-paid employee
55$254,431$2,492
Barbara DucharmeVP, CD Strategy & Midwest Region
Highest-paid employee
55$202,930$25,211
Kimberly SabelkoVP, Research & Scientific Programs
Highest-paid employee
55$203,350$14,396
Megan KlinkVP, CD Strategy & West Region
Highest-paid employee
55$201,262$12,414
Timothy A NewmanVP, CD Strategy & South Region
Highest-paid employee
55$198,810$7,916
Ed DandridgeChair of the Board
Trustee or director, Officer
1$0$0
Jerri JohnsonVice Chair
Trustee or director, Officer
1$0$0
BJ SchaknowskiBOD Member
Trustee or director
1$0$0
16 more people on this return
NameTitleHours / weekCompensation
Boris DolgonosBOD Member (ending March 2025)
Trustee or director
1$0
Charles RockefellerBOD Member
Trustee or director
1$0
Christina MinnisBOD Member
Trustee or director
1$0
Elizabeth Saint-AignanBOD Member
Trustee or director
1$0
Gail HeimannBOD Member
Trustee or director
1$0
Julie GruberBOD Member
Trustee or director
1$0
Kathy SutherlandBOD Member
Trustee or director
1$0
Kim BlackwellBOD Member
Trustee or director
1$0
Kristen MapleBOD Member (ending March 2025)
Trustee or director
1$0
Luke SauterBOD Member
Trustee or director
1$0
Lydia TheBOD Member (ending March 2025)
Trustee or director
1$0
Michelle BottomleyBOD Member
Trustee or director
1$0
Paige RossBOD Member (beginning March 2025)
Trustee or director
1$0
Peter BrundageBOD Member
Trustee or director
1$0
Robyn ShepherdBOD Member
Trustee or director
1$0
Valerie RaineyBOD Member
Trustee or director
1$0
990 for the year ended March 31, 2024: 30 people
NameTitleHours / weekCompensationOther / benefits
Paula SchneiderPresident and CEO
Officer
55$936,700$40,568
Ria WilliamsChief Fin & Ops Officer
Officer
55$339,735$48,233
Victoria SmartSVP, Mission
Key employee
55$336,530$21,751
Catherine OlivieriSVP, Human Resources
Key employee
55$284,819$31,221
Eunice NakamuraGeneral Counsel and Corporate Secretary
Officer
55$288,277$24,192
Sarah RosalesVP, Corporate Partnerships
Key employee
55$265,317$32,342
Kari BodellVP, Development Programs Strategy
Highest-paid employee
55$241,745$15,926
Kathryn WattVP, Marketing Strategy
Key employee
55$234,686$8,628
Kim SabelkoVP, Scientific Strategy & Programs
Highest-paid employee
55$213,062$23,943
Catherine StoneVP, Community Health
Highest-paid employee
55$217,001$14,809
Lori MarisSVP, OPS SERVICES & SUPPORT
Highest-paid employee
55$205,316$15,867
Rachel DaviesVP, Marketing & Communications
Highest-paid employee
55$193,992$15,483
Ed DandridgeChair of the Board
Trustee or director, Officer
1$0$0
Jerri JohnsonBOD MEMBER (VICE CHAIR)
Trustee or director, Officer
1$0$0
BJ SchaknowskiBOD Member
Trustee or director
1$0$0
Boris DolgonosBOD Member
Trustee or director
1$0$0
Charles RockefellerBOD Member
Trustee or director
1$0$0
Christina MinnisBOD Member
Trustee or director
1$0$0
Elizabeth Saint-AignanBOD Member
Trustee or director
1$0$0
Gail HeimannBOD Member
Trustee or director
1$0$0
Julie GruberBOD Member
Trustee or director
1$0$0
Kathy SutherlandBOD Member
Trustee or director
1$0$0
Kim BlackwellBOD Member
Trustee or director
1$0$0
Kristen MapleBOD Member
Trustee or director
1$0$0
Luke SauterBOD Member
Trustee or director
1$0$0
Lydia TheBOD Member
Trustee or director
1$0$0
Michelle BottomleyBOD Member
Trustee or director
1$0$0
Peter BrundageBOD Member
Trustee or director
1$0$0
Robyn ShepherdBOD Member
Trustee or director
1$0$0
Valerie RaineyBOD Member
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
PO BOX 801889, DALLAS, TX 75380-1889
In care of
% RIA WILLIAMS
Principal officer (990 for 2024)
RIA WILLIAMS, 13770 NOEL ROAD SUITE 801889, DALLAS, TX 75380
Signed the 990
RIA WILLIAMS, CHIEF FINANCIAL OFFCIER
Phone
(972) 855-1600
Return prepared by
ERNST & YOUNG US LLP

Mission

SUSAN G. KOMEN HAS AN UNMATCHED, COMPREHENSIVE 360-DEGREE APPROACH TO FIGHTING BREAST CANCER ACROSS ALL FRONTS AND SUPPORTING MILLIONS OF PEOPLE IN THE U.S. AND IN COUNTRIES WORLDWIDE. WE ADVOCATE FOR POLICIES TO PROTECT PATIENTS, DRIVE RESEARCH BREAKTHROUGHS, IMPROVE ACCESS TO HIGH-QUALITY CARE, OFFER DIRECT PATIENT NAVIGATION AND SUPPORT SERVICES AND EMPOWER PEOPLE WITH TRUSTWORTHY INFORMATION. KOMEN REMAINS COMMITTED TO SUPPORTING THOSE AFFECTED BY BREAST CANCER TODAY, WHILE TIRELESSLY SEARCHING FOR TOMORROW'S CURES.

990 for the year ended March 31, 2025

Program accomplishments

  • PATIENT CARE: PROVISION OF BREAST HEALTH EDUCATION, BREAST CANCER PATIENT NAVIGATION SERVICES, AND FINANCIAL ASSISTANCE DIRECTLY BY KOMEN TO SUPPORT ACCESS TO SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS AS WELL AS GRANTS TO OTHER NON-PROFIT ORGANIZATIONS AND THIRD-PARTY CONTRACTS, WITH A FOCUS ON SERVING COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS.
    Expenses $47,390,113 · grants $7,687,029
  • RESEARCH: KOMEN-LED RESEARCH & SCIENTIFIC PROGRAMS AND GRANTS AWARDED TO RESEARCH INSTITUTIONS AND OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS INCLUDING THOSE FOCUSED-ON RESEARCH PRIORITIES THAT WILL MAKE THE BIGGEST DIFFERENCE FOR PATIENTS: CONQUERING METASTATIC AND AGGRESSIVE BREAST CANCERS, ADVANCING PERSONALIZED BREAST CARE AND ELIMINATING BREAST CANCER DISPARITIES TO IMPROVE OUTCOMES FOR EVERYONE IMPACTED BY BREAST CANCER. SEE SCHEDULE O FOR ADDITIONAL DETAILS.
    Expenses $18,085,047 · grants $10,893,941
  • PUBLIC POLICY AND ADVOCACY: BREAST CANCER-RELATED INITIATIVES THAT HAVE THE POTENTIAL TO IMPACT ALL PEOPLE, INCLUDING ACTIVITIES ADVOCATING FOR LEGISLATIVE, REGULATORY AND OTHER POLICY SOLUTIONS DESIGNED TO SUPPORT KEY PATIENT PROTECTIONS, ENSURE ACCESS TO HIGH-QUALITY AFFORDABLE CARE, ALLEVIATE FINANCIAL AND ADMINISTRATIVE BURDENS AND FUND CRITICAL BREAST CANCER RESEARCH. SEE SCHEDULE O FOR DETAILS.
    Expenses $5,753,937

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in March, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025March 31, 2026August 17, 2026Not on file
2024March 31, 2025August 15, 2025990 on file
2023March 31, 2024August 15, 2024990 on file

IRS record

EIN
75-1835298
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Group exemption
Exempt since
1992
Accounting year ends
March
Files
Form 990 or 990-EZ
Group exemption
7164 (4 member organizations)
Assets (IRS master file)
$178,872,555
Income (IRS master file)
$138,937,712

Filing history

FormYear endedRevenueExpensesAssetsReturn
990March 2025$103,154,379$110,497,282$178,872,555XML
990-TMarch 2025–––IRS
990March 2024$102,934,186$111,489,604$188,139,545XML
990-TMarch 2024–––IRS
990March 2023$107,597,705$117,063,869$192,631,082IRS
990-TMarch 2023–––IRS
990March 2022$111,261,456$100,632,384$207,354,061IRS
990-TMarch 2022–––IRS
990March 2021–––IRS
990-TMarch 2021–––IRS
990March 2020–––IRS
990March 2019–––IRS
990March 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 75-1835298).

Questions about SUSAN G KOMEN BREAST CANCER FOUNDATION

What is the EIN of SUSAN G KOMEN BREAST CANCER FOUNDATION?
The employer identification number (EIN) of SUSAN G KOMEN BREAST CANCER FOUNDATION is 75-1835298.
Is SUSAN G KOMEN BREAST CANCER FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1992.
Are donations to SUSAN G KOMEN BREAST CANCER FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Group exemption).
Which annual return does SUSAN G KOMEN BREAST CANCER FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SUSAN G KOMEN BREAST CANCER FOUNDATION due?
The return for tax year 2025 (the year ending March 31, 2026) is due August 17, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SUSAN G KOMEN BREAST CANCER FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended March 2025.
Who is the principal officer of SUSAN G KOMEN BREAST CANCER FOUNDATION?
The 990 for the year ended March 31, 2025 names RIA WILLIAMS.
Who are the officers and directors of SUSAN G KOMEN BREAST CANCER FOUNDATION?
The 990 for the year ended March 31, 2025 lists 31 people; 12 received compensation from the organization, the highest $658,115 (Paula Schneider, President and CEO).
How much revenue does SUSAN G KOMEN BREAST CANCER FOUNDATION have?
On its 990 for the year ended March 31, 2025 it reported revenue of $103,154,379, expenses of $110,497,282 and total assets of $178,872,555 at year end.

Organizations in its group exemption (4)

Other nonprofits in DALLAS

All nonprofits in DALLAS · Texas · Voluntary health associations and medical disciplines